Health Care • Medical/Dental Instruments
$1.12 ▲ +0.00
(0.00%)
MKT CAP: $75.2M • VOL: 968.4K
52W L $1 52W H $3
ROARABLE / RQD
D- • 41/100
PIOTROSKI
2 / 9
MBOT // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $0 | $0 | $0 |
| YoY Revenue Growth % | — | — | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$14.7M | -$11.6M | -$9.9M |
| Operating Margin % | — | — | — |
| Net Income (GAAP) | -$13.1M | -$11.4M | -$10.7M |
| EBITDA (Normalized) | -$14.7M | -$11.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$13.0M | -$8.8M | -$8.5M |
| Capital Expenditures (CapEx) | $60.0K | $25.0K | — |
| Free Cash Flow (FCF) | -$13.1M | -$8.9M | -$8.5M |
| FCF Margin % | — | — | — |
| Return on Invested Capital (ROIC %) | -15.8% | -45.0% | — |
| Cash & Short-Term Equivalents | $3.9M | $3.1M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $77.6M | $3.5M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR MBOT.